PB

Pignesh Bhogilal Patel

Active Director Director DIN 10845864
DIN 10845864 First appointment Nov 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Pignesh Bhogilal Patel

Data last updated:

Pignesh Bhogilal Patel is a Director at Sovyyn Pharmaceuticals Private Limited (since 2024). The company operates in Healthcare.

DIN 10845864
Primary Designation Director
Industry Healthcare
First Appointment 21 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20242024Active

Board colleagues of Pignesh Bhogilal Patel

NameDINCompanyDesignation
Dhaval Janakkumar Modi10845863Sovyyn Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sovyyn Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pignesh Bhogilal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pignesh Bhogilal Patel

Pignesh Bhogilal Patel currently holds 1 directorship: Sovyyn Pharmaceuticals Private Limited (Director, since 21 Nov 2024).

Pignesh Bhogilal Patel was first appointed on 21 Nov 2024 as Director at Sovyyn Pharmaceuticals Private Limited.

The current boards of Pignesh Bhogilal Patel's companies include Dhaval Janakkumar Modi (Sovyyn Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available